{"document_url": "https://en.wikipedia.org/wiki/Tabernanthalog"}
Chemical compound

Tabernanthalog is a novel water-soluble, non-toxic azepinoindole analog of the psychoactive drug ibogaine first synthesized by Professor David E. Olson at UC Davis.

In rodents, it was found to promote structural neural plasticity, reduce drug seeking behavior, and produce antidepressant like effects. Due to the rapidly-induced and enduring neuroplasticity, Tabernanthalog is a member of the class of compounds known as non-hallucinogenic psychoplastogens. This compound, as well as related compounds, are licensed by Delix Therapeutics and are being developed as potential medicines for neuropsychiatric disorders.